Search research articles
Contact Us
Filters
Showing results (121-130 of 139) with videos related to
Page
of 14
Sort By:
JCO Global Oncology
|
December 3, 2021
Accuracy of Pathologic Diagnosis in Patients With Lymphoma and Survival: A Prospective Analysis From Botswana
Fallon E Chipidza, Mukendi K A Kayembe, Isaac Nkele, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2004
Prostate-specific antigen doubling time as a surrogate marker for evaluation of oncologic drugs to treat prostate cancer
Gary J Kelloff, Donald S Coffey, Bruce A Chabner, et al.
The Oncologist
|
April 19, 2002
Between parent and child: negotiating cancer treatment in adolescents
Richard T Penson, Paula K Rauch, Steve L McAfee, et al.
JAMA
|
November 4, 2004
Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials
Thomas G Roberts, Bernardo H Goulart, Lee Squitieri, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 14, 2015
A Roadmap for a New Academic Pathway for Global Radiation Oncology
Adam C Olson, C Norman Coleman, Stephen M Hahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2004
Rationale for biomarkers and surrogate end points in mechanism-driven oncology drug development
John W Park, Robert S Kerbel, Gary J Kelloff, et al.
Clinical Colorectal Cancer
|
March 18, 2004
Dihydropyrimidine dehydrogenase and thymidylate synthase polymorphisms and their association with 5-fluorouracil/leucovorin chemotherapy in colorectal cancer
Andrew X Zhu, Thomas A Puchalski, Vincent P Stanton, et al.
The Oncologist
|
May 29, 2020
A Phase II Trial of Cabozantinib in Hormone Receptor-Positive Breast Cancer with Bone Metastases
Jing Xu, Michaela J Higgins, Sara M Tolaney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 2, 2008
Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers
Wyndham H Wilson, Kieron Dunleavy, Stefania Pittaluga, et al.
Theranostics
|
July 23, 2016
Holographic Assessment of Lymphoma Tissue (HALT) for Global Oncology Field Applications
Divya Pathania, Hyungsoon Im, Aoife Kilcoyne, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 139) with videos related to
Sort By:
Page
of 14
JCO Global Oncology
|
December 3, 2021
Accuracy of Pathologic Diagnosis in Patients With Lymphoma and Survival: A Prospective Analysis From Botswana
Fallon E Chipidza, Mukendi K A Kayembe, Isaac Nkele, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2004
Prostate-specific antigen doubling time as a surrogate marker for evaluation of oncologic drugs to treat prostate cancer
Gary J Kelloff, Donald S Coffey, Bruce A Chabner, et al.
The Oncologist
|
April 19, 2002
Between parent and child: negotiating cancer treatment in adolescents
Richard T Penson, Paula K Rauch, Steve L McAfee, et al.
JAMA
|
November 4, 2004
Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials
Thomas G Roberts, Bernardo H Goulart, Lee Squitieri, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 14, 2015
A Roadmap for a New Academic Pathway for Global Radiation Oncology
Adam C Olson, C Norman Coleman, Stephen M Hahn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 3, 2004
Rationale for biomarkers and surrogate end points in mechanism-driven oncology drug development
John W Park, Robert S Kerbel, Gary J Kelloff, et al.
Clinical Colorectal Cancer
|
March 18, 2004
Dihydropyrimidine dehydrogenase and thymidylate synthase polymorphisms and their association with 5-fluorouracil/leucovorin chemotherapy in colorectal cancer
Andrew X Zhu, Thomas A Puchalski, Vincent P Stanton, et al.
The Oncologist
|
May 29, 2020
A Phase II Trial of Cabozantinib in Hormone Receptor-Positive Breast Cancer with Bone Metastases
Jing Xu, Michaela J Higgins, Sara M Tolaney, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 2, 2008
Phase II study of dose-adjusted EPOCH and rituximab in untreated diffuse large B-cell lymphoma with analysis of germinal center and post-germinal center biomarkers
Wyndham H Wilson, Kieron Dunleavy, Stefania Pittaluga, et al.
Theranostics
|
July 23, 2016
Holographic Assessment of Lymphoma Tissue (HALT) for Global Oncology Field Applications
Divya Pathania, Hyungsoon Im, Aoife Kilcoyne, et al.
Page
of 14